Below are the most recent publications written about "Organophosphorus Compounds" by people in Profiles.
-
Kirkman DL, Muth BJ, Ramick MG, Townsend RR, Edwards DG. Role of mitochondria-derived reactive oxygen species in microvascular dysfunction in chronic kidney disease. Am J Physiol Renal Physiol. 2018 03 01; 314(3):F423-F429.
-
Kirby SD, Norris JR, Richard Smith J, Bahnson BJ, Cerasoli DM. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents. Chem Biol Interact. 2013 Mar 25; 203(1):181-5.
-
Krishna OD, Jha AK, Jia X, Kiick KL. Integrin-mediated adhesion and proliferation of human MSCs elicited by a hydroxyproline-lacking, collagen-like peptide. Biomaterials. 2011 Sep; 32(27):6412-24.
-
Valicenti RK, Trabulsi E, Intenzo C, Lavarino J, Xu Y, Chervoneva I. A Phase I trial of samarium-153-lexidronam complex for treatment of clinically nonmetastatic high-risk prostate cancer: first report of a completed study. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):732-7.
-
Kirk BA, Cusack CL, Laager E, Rochlis E, Thomas T, Cassano AG. Mononuclear and dinuclear mechanisms for catalysis of phosphodiester cleavage by alkaline earth metal ions in aqueous solution. J Inorg Biochem. 2010 Feb; 104(2):207-10.
-
Samanta U, Kirby SD, Srinivasan P, Cerasoli DM, Bahnson BJ. Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes. Biochem Pharmacol. 2009 Aug 15; 78(4):420-9.
-
Morris MJ, Pandit-Taskar N, Carrasquillo J, Divgi CR, Slovin S, Kelly WK, Rathkopf D, Gignac GA, Solit D, Schwartz L, Stephenson RD, Hong C, Delacruz A, Curley T, Heller G, Jia X, O'Donoghue J, Larson S, Scher HI. Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer. J Clin Oncol. 2009 May 20; 27(15):2436-42.
-
Belinsky MG, Dawson PA, Shchaveleva I, Bain LJ, Wang R, Ling V, Chen ZS, Grinberg A, Westphal H, Klein-Szanto A, Lerro A, Kruh GD. Analysis of the in vivo functions of Mrp3. Mol Pharmacol. 2005 Jul; 68(1):160-8.
-
Reddy GK, Gibson TB, Hutson T, Marianni S, Sartor O. Highlights from the 2005 American Society of Clinical Oncology Prostate Cancer Symposium, Orlando, Florida. Clin Prostate Cancer. 2005 Mar; 3(4):206-10.
-
Wachsberger PR, Burd R, Marero N, Daskalakis C, Ryan A, McCue P, Dicker AP. Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):835-42.